Newsroom


Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

DURHAM, NC – January 11, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…

Read More

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

DURHAM, NC – December 28, 2021 – Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali,…

Read More

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

DURHAM, NC – December 21, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

DURHAM, NC – December 20, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…

Read More

Bioventus to Expand Operations and Manufacturing in Memphis

MEMPHIS, TN – November 18, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Announces Chief Financial Officer Transition Plan

DURHAM, NC – November 15, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing,…

Read More

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

DURHAM, NC – November 9, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…

Read More

Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs

DURHAM, NC – November 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Completes the Acquisition of Misonix

DURHAM, NC – October 29, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

DURHAM, NC – October 27, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Search News


Media Inquiries


Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]

Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now